John N. Whitaker

2.5k total citations
44 papers, 1.7k citations indexed

About

John N. Whitaker is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John N. Whitaker has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Pathology and Forensic Medicine and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John N. Whitaker's work include Multiple Sclerosis Research Studies (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Glycosylation and Glycoproteins Research (10 papers). John N. Whitaker is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Glycosylation and Glycoproteins Research (10 papers). John N. Whitaker collaborates with scholars based in United States, Australia and United Kingdom. John N. Whitaker's co-authors include Jerome M. Seyer, B. Kitze, Hartmut Wekerle, Eliseo Albert, M. Pette, Kyoko Fujita, Richard I. Carp, Richard Race, William H. Frey and J.F. Diedrich and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Neurology.

In The Last Decade

John N. Whitaker

44 papers receiving 1.6k citations

Peers

John N. Whitaker

PFM

IMMUN

NEURO

RHEUM

Miguel Lucas Spain

Bernadette Kálmán United States

H.‐P. Hartung Germany

R Gonsette Belgium

José C. Álvarez‐Cermeño Spain

Katsuichi Miyamoto Japan

Maddalena Ruggieri Italy

Assunta Dal‐Bianco Austria

Erik Wallström Sweden

Ulf Schulze‐Topphoff United States

Miguel Lucas Spain

John N. Whitaker

338 ×0.5

PFM

807 ×1.6

407 ×1.0

IMMUN

244 ×0.6

NEURO

180 ×0.7

RHEUM

Citations per year, relative to John N. Whitaker John N. Whitaker (= 1×) peers Miguel Lucas

Countries citing papers authored by John N. Whitaker

Since Specialization

Citations

This map shows the geographic impact of John N. Whitaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John N. Whitaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John N. Whitaker more than expected).

Fields of papers citing papers by John N. Whitaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John N. Whitaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John N. Whitaker. The network helps show where John N. Whitaker may publish in the future.

Co-authorship network of co-authors of John N. Whitaker

This figure shows the co-authorship network connecting the top 25 collaborators of John N. Whitaker. A scholar is included among the top collaborators of John N. Whitaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John N. Whitaker. John N. Whitaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cohen, Jeffrey A., Gary Cutter, Jill S. Fischer, et al.. (2002). Benefit of interferon β-1a on MSFC progression in secondary progressive MS. Neurology. 59(5). 679–687. 307 indexed citations

Kirk, Marion, et al.. (2000). p-Cresol Sulfate Is the Dominant Component of Urinary Myelin Basic Protein Like Material. Archives of Biochemistry and Biophysics. 377(1). 9–21. 22 indexed citations

Blalock, J. Edwin, et al.. (1999). Highly related immunoglobulin light chain sequences in different multiple sclerosis patients. Journal of Neuroimmunology. 100(1-2). 98–101. 4 indexed citations

Whitaker, John N., et al.. (1999). Urinary Myelin Basic Protein–like Material in Patients With Multiple Sclerosis During Interferon Beta-1b Treatment. Archives of Neurology. 56(6). 687–687. 5 indexed citations

Sun, Deming, Christopher Coleclough, Rong Ji, Xianzhen Hu, & John N. Whitaker. (1999). Alanine-substituted peptide ligands differ greatly in their ability to activate autoreactive T-cell subsets specific for the wild-type peptide. Journal of Neuroimmunology. 99(1). 105–113. 3 indexed citations

Lublin, Fred, John N. Whitaker, Benjamin H. Eidelman, et al.. (1996). Management of patients receiving interferon beta-1b for multiple sclerosis. Neurology. 46(1). 12–18. 125 indexed citations

Rawal, Nenoo, et al.. (1995). Urinary excretion of NG-dimethylarginines in multiple sclerosis patients: preliminary observations. Journal of the Neurological Sciences. 129(2). 186–191. 28 indexed citations

Maier, Curtis C., F. Shawn Galin, Peter Jackson, et al.. (1994). A V lambda x-bearing monoclonal antibody with similar specificity and sequence to encephalitogenic T cell receptors.. The Journal of Immunology. 153(3). 1132–1140. 8 indexed citations

Whitaker, John N., et al.. (1994). Use of Complementary Peptides and Their Antibodies in T-Cell-Mediated Autoimmune Disease: Experiments with Myelin Basic Protein. PubMed. 5(2). 136–147. 6 indexed citations

10.

Maier, Curtis C., et al.. (1994). Identification of Interactive Determinants on Idiotypic-Anti-idiotypic Antibodies through Comparison of Their Hydropathic Profiles. PubMed. 5(2). 107–113. 14 indexed citations

11.

Whitaker, John N., et al.. (1994). Monoclonal and polyclonal antibody responses to the myelin basic protein epitope present in human urine. Journal of Neuroimmunology. 52(1). 53–60. 8 indexed citations

12.

Maier, Curtis C., et al.. (1993). The structure of a myelin basic protein-associated idiotope. Journal of Neuroimmunology. 46(1-2). 235–243. 5 indexed citations

13.

Whitaker, John N.. (1993). Expanded clinical trials of treatments for multiple sclerosis. Annals of Neurology. 34(6). 755–756. 2 indexed citations

14.

Whitaker, John N., et al.. (1993). Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies. The Journal of Immunology. 150(4). 1629–1642. 47 indexed citations

15.

Whitaker, John N., et al.. (1991). Cerebrospinal fluid levels of myelin basic protein-like material and soluble interleukin-2 receptor in multiple sclerosis. Journal of Neuroimmunology. 34(1). 77–80. 12 indexed citations

16.

Whitaker, John N., et al.. (1990). An idiotype shared by monoclonal antibodies to different peptides of human myelin basic protein.. The Journal of Immunology. 145(8). 2554–2560. 15 indexed citations

17.

Whitaker, John N.. (1987). The presence of immunoreactive myelin basic protein peptide in urine of persons with multiple sclerosis. Annals of Neurology. 22(5). 648–655. 36 indexed citations

18.

Whitaker, John N., et al.. (1986). Multiple epitopes in a dodecapeptide of myelin basic protein determined by monoclonal antibodies.. The Journal of Immunology. 136(7). 2426–2431. 21 indexed citations

19.

Mingioli, Elizabeth S., W Strober, W. W. Tourtellotte, John N. Whitaker, & D. E. McFarlin. (1978). Quantitation of IgG, IgA and IgM in the CSF by radioimmunoassay. Neurology. 28(10). 991–991. 45 indexed citations

20.

Whitaker, John N., et al.. (1976). Immunogenetic Analysis and Serum Viral Antibody Titers in Multiple Sclerosis. Archives of Neurology. 33(6). 399–403. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact